This page is intended for healthcare professionals

This page is intended for healthcare professionals

Testogel 16.2 mg/g gel is indicated in adults as testosterone replacement therapy for male hypogonadism when testosterone deficiency has been confirmed by clinical features and biochemical tests.

WHAT DOES A MAN WITH TESTOSTERONE DEFICIENCY STAND TO LOSE?

Testosterone Deficiency (TD) can affect many aspects of a man’s life; it is important for both physical and emotional well-being. Testosterone is responsible for many things in the body including maintaining muscle and bone mass, the production of sperm, and the desire to have sex.1-3


When the levels of testosterone drop abnormally low it may affect the overall health and quality of life for men in a variety of different ways.1-3

WHAT DOES A MAN WITH TESTOSTERONE DEFICIENCY STAND TO LOSE?

Testosterone Deficiency (TD) can affect many aspects of a man’s life; it is important for both physical and emotional well-being. Testosterone is responsible for many things in the body including maintaining muscle and bone mass, the production of sperm, and the desire to have sex.1-3


When the levels of testosterone drop abnormally low it may affect the overall health and quality of life for men in a variety of different ways.1-3

SEXUAL DYSFUNCTION1-3

  • Low sex drive
  • Difficulty achieving orgasm
  • Difficulty in getting or keeping an erection (i.e. weak or no morning erections)
REDUCED WELLBEING1-3

  • Tiredness
  • Low mood or depression
  • Loss of concentration
  • Irritability
PHYSICAL DECLINE1-3

  • Weight gain
  • Breast development (gynaecomastia)
  • Hot flushes and sweats
  • Loss of muscle and strength
  • Loss of body hair
An airfix of a tired man napping on a couch
THE PREVALENCE OF Testosterone Deficiency MAY BE HIGHER WHEN MEN HAVE OTHER CONDITIONS SUCH AS:4

TYPE II DIABETES

OBESITY

HYPERLIPIDAEMIA

HYPERTENSION

CHRONIC OPIOID USE

MODERATE TO SEVERE COPD

THE PREVALENCE OF TDS IS HIGHER WHEN MEN HAVE OTHER CONDITIONS SUCH AS:4
TESTOSTERONE THERAPY AND SUITABILITY GUIDELINES

Watch Professor Abraham Morgentaler of the Harvard Medical School in Boston discuss Testosterone Therapy and Who it is Suitable for.

TESTOSTERONE THERAPY AND SUITABILITY GUIDELINES

Watch Professor Abraham Morgentaler of the Harvard Medical School in Boston discuss Testosterone Therapy and Who it is Suitable for.

TESTOSTERONE THERAPY AND SUITABILITY GUIDELINES

Watch Professor Abraham Morgentaler of the Harvard Medical School in Boston discuss Testosterone Therapy and Who it is Suitable for.

References:

1. The Endocrine Society’s Clinical Guidelines: Testosterone therapy in adult men with androgen deficiency syndromes. 2010. Available at: https://academic.oup.com/jcem/article/95/6/2536/2597900
Accessed: February 2018.

2. The British Society for Sexual Medicine Guidelines on Adult Testosterone Deficiency, With Statements for UK Practice. 2017. Available at: http://www.bssm.org.uk/wp-content/uploads/2018/09/guidelines-on-adult-testosterone-deficiency-with-statements-for-uk-practice.pdf Accessed November 2018.

3. Lunenfeld B et al. Aging Male 2013; 16: 143–150.

4. Khera M et al. J Sex Med 2016; 13: 1787-1804.

ADVERSE EVENT REPORTING

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Besins Healthcare (UK) Ltd Drug Safety on 0203 862 0920 or Email: drugsafety@besins-healthcare.com

This page is intended for healthcare professionals

© 2018 BESINS HEALTHCARE LTD. TES/2018/075A Date of Preparation November 2018.

API